Cefprozil
NDC 65862-099, Cefprozil, powder, for suspension, from Aurobindo Pharma Limited.
- Product NDC
- 65862-099
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA065381
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CEFPROZIL125 mg/5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-099-01 | 65862009901 | 100 mL in 1 BOTTLE (65862-099-01) |
| 65862-099-50 | 65862009950 | 50 mL in 1 BOTTLE (65862-099-50) |
| 65862-099-75 | 65862009975 | 75 mL in 1 BOTTLE (65862-099-75) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/97675251-70b8-43bc-93ea-f9ef6bb8cb68
Use it
Look up 65862-099 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-099. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.